{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:56:45Z","timestamp":1786993005337,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jneuroim.2023.578085","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T20:04:44Z","timestamp":1680897884000},"page":"578085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neuro-Sj\u00f6gren: A clinical-radiological paradox affecting the central nervous system"],"prefix":"10.1016","volume":"378","author":[{"given":"Eduardo","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"de Grazia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578085_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000179","article-title":"Original article: epidemiology of neurological manifestations in Sj\u00f6gren\u2019s syndrome: data from the French ASSESS cohort","volume":"2","author":"Carvajal Alegria","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0015","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","article-title":"Treatment of Sj\u00f6gren\u2019s syndrome: current therapy and future directions","volume":"60","author":"Fox","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1148\/radiology.189.1.8372197","article-title":"Neuroimaging of juvenile pilocytic astrocytomas: an enigma","volume":"189","author":"Fulham","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.03.025","article-title":"Paradoxical reaction in HIV negative tuberculous meningitis","volume":"340","author":"Garg","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163030","article-title":"A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Mariette","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sj\u00f6gren\u2019s syndrome: diagnosis and management","volume":"3","author":"McCoy","year":"2017","journal-title":"Curr. Treatm. Opt. Rheumatol."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0045","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0050","first-page":"S103","article-title":"Primary Sj\u00f6gren\u2019s syndrome: central and peripheral nervous system involvements","volume":"38","author":"Mekinian","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00234-020-02402-2","article-title":"MRI findings in Pott\u2019s spine and correlating clinical progress with radiological findings","volume":"62","author":"Misra","year":"2020","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006715","article-title":"A case report of Sj\u00f6gren syndrome manifesting bilateral basal ganglia lesions","volume":"96","author":"Niu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0065","first-page":"26","article-title":"Plasticity in MS: from functional imaging to rehabilitation","volume":"16","author":"Pelletier","year":"2009","journal-title":"Intern. MS J."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sj\u00f6gren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 spanish patients (GEAS-SS registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatol. (UK)"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780300620","article-title":"Primary Sj\u00f6gren\u2019s syndrome associated with systemic necrotizing vasculitis: a fatal case","author":"Sato","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/acn3.51123","article-title":"Cognitive impairment in patients with neuro-Sj\u00f6gren","volume":"7","author":"Seeliger","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0090","first-page":"1","article-title":"Sj\u00f6gren\u2019s syndrome with and without neurological involvement","volume":"1","author":"Seeliger","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary Sj\u00f6gren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0105","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.2482070938","article-title":"Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients","volume":"248","author":"Sluimer","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jneuroim.2023.578085_bb0110","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1136\/annrheumdis-2017-211378","article-title":"Classification and diagnostic criteria in Sj\u00f6gren\u2019s syndrome: a long-standing and still open controversy","volume":"76","author":"Vitali","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2023.578085_bb0115","series-title":"Successful treatment of refractory neuroSjogren with Rituximab","first-page":"521","volume":"16","author":"Yamout","year":"2016"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:26Z","timestamp":1759048946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":23,"alternative-id":["S0165572823000711"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578085","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-Sj\u00f6gren: A clinical-radiological paradox affecting the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578085"}}